Literature DB >> 24427174

Somatoform disorders among patients attending walk-in clinics in Trinidad: prevalence and association with depression and anxiety.

Rg Maharaj1, C Alexander2, C H Bridglal2, A Edwards2, H Mohammed2, Ta Rampaul2, S Sanchez2, Gp Tanwing2, K Thomas2.   

Abstract

Objectives Somatoform disorders are common in international primary care settings, but have been little studied in the developing world. The objective of this study was to determine the prevalence of severe undifferentiated somatoform disorder, and its relationship to depression and anxiety, among patients attending walk-in clinics in Trinidad. Methods The study participants, who were all aged 18 years or older and attending walk-in clinics at 16 randomly selected health centres, were surveyed between May and August 2007 using the PRIME-MD questionnaire. Results There were 594 participants (the response rate was 92%), of whom 72.7% were female. Their ages ranged from 18 to 93 years, and 54.5% were over 50 years of age. In total, 37.2% were married and 25.9% were single. Indo-Trinidadians represented 43.1% and Afro-Trinidadians represented 36% of the study sample; 56.5% of the participants reported that their income was less than US$ 400 per month, and 65.7% were unemployed. At walk-in clinics in Trinidad, the estimated prevalence of severe undifferentiated somatoform disorder was 10.3% (95% CI: 7.86-12.74), that of hypochondriasis was 28.5% (95% CI: 24.9-32.1), and that of body dysmorphic disorder was 15.8% (95% CI: 11.9-18.7). Severe undifferentiated somatoform disorder was statistically significantly associated with gender and ethnicity but not with age, level of education, employment status or income. Chi-square testing found significant associations between the presence of severe undifferentiated somatoform disorder and both depression and anxiety (P < 0.05), between hypochondriasis and both anxiety and depression (P < 0.05), and between body dysmorphic disorder and depression (P < 0.05) but not anxiety. Regression analysis suggested that the demographic features that predicted severe undifferentiated somatoform disorder were being female or Indo-Trinidadian. Conclusions Walk-in clinics in Trinidad that serve older patients on a lower income have a high proportion of patients with somatoform disorders as measured by the PRIME-MD scale. These patients exhibit many features of anxiety and depression. These findings have implications for medical training and service delivery.

Entities:  

Keywords:  body dysmorphic disorder; hypochondriasis; primary care; somatoform disorders

Year:  2013        PMID: 24427174      PMCID: PMC3822639     

Source DB:  PubMed          Journal:  Ment Health Fam Med        ISSN: 1756-834X


  15 in total

1.  Patients with psychiatric disorders in gynecologic practice--a three year follow-up.

Authors:  Malin Malmenström; Marie Bixo; Inger Björn; Monica Aström; Inger Sundström Poromaa
Journal:  J Psychosom Obstet Gynaecol       Date:  2006-03       Impact factor: 2.949

2.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

3.  Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition.

Authors:  P Fink; L Sørensen; M Engberg; M Holm; P Munk-Jørgensen
Journal:  Psychosomatics       Date:  1999 Jul-Aug       Impact factor: 2.386

4.  [Mental disorders in a sample of pregnant women receiving primary health care in Southern Brazil].

Authors:  Michele Scortegagna de Almeida; Maria Angélica Nunes; Suzi Camey; Andrea Poyastro Pinheiro; Maria Inês Schmidt
Journal:  Cad Saude Publica       Date:  2012-02       Impact factor: 1.632

5.  Enabling the diagnosis of occult psychiatric illness in the emergency department: a randomized, controlled trial of the computerized, self-administered PRIME-MD diagnostic system.

Authors:  D L Schriger; P S Gibbons; C A Langone; S Lee; L L Altshuler
Journal:  Ann Emerg Med       Date:  2001-02       Impact factor: 5.721

6.  High prevalence of mental disorders in primary care.

Authors:  M Ansseau; M Dierick; F Buntinkx; P Cnockaert; J De Smedt; M Van Den Haute; D Vander Mijnsbrugge
Journal:  J Affect Disord       Date:  2004-01       Impact factor: 4.839

7.  Use of the PRIME-MD Patient Health Questionnaire for estimating the prevalence of psychiatric disorders in French primary care: comparison with family practitioner estimates and relationship to psychotropic medication use.

Authors:  Joanna Norton; Guilhem De Roquefeuil; Jean-Philippe Boulenger; Karen Ritchie; Anthony Mann; Andre Tylee
Journal:  Gen Hosp Psychiatry       Date:  2007 Jul-Aug       Impact factor: 3.238

8.  Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders.

Authors:  Margot W M de Waal; Ingrid A Arnold; Just A H Eekhof; Albert M van Hemert
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

9.  Follow-up study on health care use of patients with somatoform, anxiety and depressive disorders in primary care.

Authors:  Margot W M de Waal; Ingrid A Arnold; Just A H Eekhof; Willem J J Assendelft; Albert M van Hemert
Journal:  BMC Fam Pract       Date:  2008-01-24       Impact factor: 2.497

10.  Depression and the nature of Trinidadian family practice: a cross-sectional study.

Authors:  Rohan G Maharaj
Journal:  BMC Fam Pract       Date:  2007-04-26       Impact factor: 2.497

View more
  2 in total

1.  25 Hydroxyvitamin D levels, quality of life, and disability in long-standing patients of somatization.

Authors:  Shruti Srivastava; Manjeet Singh Bhatia; Priyanka Gautam
Journal:  Ind Psychiatry J       Date:  2018 Jan-Jun

2.  An investigation of pain intensity patterns and psychosomatic symptoms among the cardiac patients admitted to an Iranian hospital.

Authors:  Mostafa Bahremand; Afsaneh Shahbazirad; Gholamreza Moradi; Abdolhamid Zokaei
Journal:  Caspian J Intern Med       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.